| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphatidylinositol 3-Kinases | 41 | 2022 | 2938 | 4.650 |
Why?
|
| PTEN Phosphohydrolase | 18 | 2023 | 1142 | 3.180 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 23 | 2021 | 890 | 3.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 7 | 2022 | 538 | 2.210 |
Why?
|
| Cyclin-Dependent Kinase 6 | 5 | 2022 | 322 | 2.140 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 8 | 2021 | 74 | 1.790 |
Why?
|
| Phosphatidylinositol 3-Kinase | 5 | 2023 | 130 | 1.740 |
Why?
|
| Breast Neoplasms | 28 | 2023 | 20822 | 1.370 |
Why?
|
| Protein Kinase Inhibitors | 13 | 2023 | 5535 | 1.310 |
Why?
|
| Cell Transformation, Neoplastic | 14 | 2018 | 2942 | 1.240 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2023 | 137 | 1.210 |
Why?
|
| TOR Serine-Threonine Kinases | 8 | 2018 | 2109 | 1.070 |
Why?
|
| Neoplasms | 22 | 2022 | 21683 | 1.010 |
Why?
|
| Signal Transduction | 44 | 2023 | 23403 | 1.000 |
Why?
|
| Receptor, erbB-2 | 10 | 2023 | 2416 | 0.960 |
Why?
|
| Morpholines | 9 | 2019 | 571 | 0.890 |
Why?
|
| Protein Isoforms | 7 | 2020 | 1730 | 0.870 |
Why?
|
| Multiprotein Complexes | 4 | 2018 | 1119 | 0.870 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2013 | 111 | 0.860 |
Why?
|
| Mice | 70 | 2023 | 81183 | 0.840 |
Why?
|
| Aminopyridines | 7 | 2019 | 542 | 0.810 |
Why?
|
| Protein Biosynthesis | 3 | 2018 | 2126 | 0.810 |
Why?
|
| Drug Resistance, Neoplasm | 12 | 2023 | 5172 | 0.810 |
Why?
|
| Proto-Oncogene Proteins c-akt | 12 | 2022 | 2503 | 0.780 |
Why?
|
| Brain Neoplasms | 10 | 2023 | 8863 | 0.780 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2023 | 520 | 0.770 |
Why?
|
| Cell Line, Tumor | 32 | 2023 | 16689 | 0.770 |
Why?
|
| Mitosis | 3 | 2023 | 1208 | 0.760 |
Why?
|
| Animals | 85 | 2023 | 168757 | 0.720 |
Why?
|
| Ovarian Neoplasms | 5 | 2023 | 4838 | 0.700 |
Why?
|
| Cell Cycle | 7 | 2023 | 2967 | 0.700 |
Why?
|
| Immune Evasion | 1 | 2023 | 360 | 0.700 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2016 | 92 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2020 | 8428 | 0.690 |
Why?
|
| Cell Proliferation | 17 | 2022 | 10481 | 0.670 |
Why?
|
| Antineoplastic Agents | 17 | 2022 | 13695 | 0.670 |
Why?
|
| RNA-Binding Proteins | 3 | 2018 | 1903 | 0.660 |
Why?
|
| BRCA1 Protein | 3 | 2022 | 1149 | 0.640 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2019 | 671 | 0.640 |
Why?
|
| Mammary Glands, Animal | 3 | 2017 | 276 | 0.610 |
Why?
|
| Hematopoiesis | 3 | 2019 | 2072 | 0.600 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.570 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 360 | 0.550 |
Why?
|
| Molecular Targeted Therapy | 4 | 2022 | 2727 | 0.540 |
Why?
|
| Receptor, trkB | 1 | 2016 | 125 | 0.530 |
Why?
|
| Isoenzymes | 5 | 2015 | 1726 | 0.510 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2020 | 2916 | 0.510 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 720 | 0.490 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2014 | 20 | 0.480 |
Why?
|
| Epithelial Cells | 7 | 2017 | 3690 | 0.460 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 1213 | 0.450 |
Why?
|
| Mammary Glands, Human | 2 | 2005 | 199 | 0.440 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 7722 | 0.440 |
Why?
|
| Muscle Development | 1 | 2015 | 271 | 0.440 |
Why?
|
| Immunity | 1 | 2018 | 1012 | 0.430 |
Why?
|
| Phosphorylation | 11 | 2019 | 8436 | 0.420 |
Why?
|
| Genes, ras | 2 | 2014 | 690 | 0.400 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 2007 | 258 | 0.400 |
Why?
|
| Oncogene Proteins | 3 | 2018 | 749 | 0.400 |
Why?
|
| Astrocytoma | 1 | 2016 | 790 | 0.400 |
Why?
|
| Mice, Nude | 10 | 2018 | 3689 | 0.400 |
Why?
|
| Immunotherapy | 3 | 2023 | 4445 | 0.390 |
Why?
|
| Polyomavirus | 2 | 2012 | 248 | 0.380 |
Why?
|
| Enzyme Inhibitors | 7 | 2019 | 3798 | 0.370 |
Why?
|
| Tumor Microenvironment | 6 | 2023 | 3586 | 0.370 |
Why?
|
| Carrier Proteins | 3 | 2018 | 5021 | 0.370 |
Why?
|
| Membrane Proteins | 6 | 2018 | 7880 | 0.360 |
Why?
|
| Glioblastoma | 3 | 2020 | 3481 | 0.350 |
Why?
|
| Anoikis | 1 | 2009 | 49 | 0.350 |
Why?
|
| Gene Dosage | 2 | 2013 | 1252 | 0.350 |
Why?
|
| Myeloproliferative Disorders | 1 | 2015 | 606 | 0.340 |
Why?
|
| Disease Models, Animal | 13 | 2019 | 18029 | 0.340 |
Why?
|
| Gene Expression Profiling | 6 | 2018 | 9438 | 0.340 |
Why?
|
| Apoptosis | 6 | 2020 | 9727 | 0.330 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2022 | 3557 | 0.330 |
Why?
|
| Humans | 88 | 2023 | 744343 | 0.330 |
Why?
|
| Astrocytes | 1 | 2016 | 1270 | 0.330 |
Why?
|
| RNA | 1 | 2018 | 2749 | 0.320 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 1581 | 0.320 |
Why?
|
| Pro-Opiomelanocortin | 3 | 2015 | 163 | 0.320 |
Why?
|
| Estrogen Receptor alpha | 3 | 2018 | 577 | 0.320 |
Why?
|
| Immunohistochemistry | 7 | 2019 | 11366 | 0.310 |
Why?
|
| Neoplasm Transplantation | 6 | 2017 | 2085 | 0.310 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5221 | 0.300 |
Why?
|
| Fibroblasts | 6 | 2016 | 4161 | 0.300 |
Why?
|
| Leukemia | 1 | 2015 | 1511 | 0.290 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2019 | 3386 | 0.290 |
Why?
|
| Oncogene Protein v-akt | 4 | 2019 | 135 | 0.280 |
Why?
|
| Phthalazines | 3 | 2018 | 363 | 0.280 |
Why?
|
| Mice, Knockout | 13 | 2019 | 14557 | 0.280 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2022 | 705 | 0.280 |
Why?
|
| Glucose | 6 | 2022 | 4397 | 0.280 |
Why?
|
| Camptothecin | 3 | 2023 | 576 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2018 | 11524 | 0.270 |
Why?
|
| Alternative Splicing | 3 | 2018 | 1117 | 0.260 |
Why?
|
| Mice, SCID | 4 | 2016 | 2716 | 0.260 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3768 | 0.260 |
Why?
|
| Female | 45 | 2023 | 380194 | 0.250 |
Why?
|
| Enzyme Activation | 6 | 2019 | 3701 | 0.250 |
Why?
|
| Mice, Transgenic | 11 | 2018 | 9734 | 0.250 |
Why?
|
| Insulin | 2 | 2010 | 6580 | 0.240 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 1353 | 0.240 |
Why?
|
| RNA, Messenger | 2 | 2018 | 13033 | 0.240 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2009 | 2948 | 0.230 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3647 | 0.230 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 2 | 2016 | 48 | 0.230 |
Why?
|
| Models, Biological | 7 | 2018 | 9583 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2022 | 1692 | 0.220 |
Why?
|
| Tankyrases | 1 | 2022 | 14 | 0.210 |
Why?
|
| Cells, Cultured | 10 | 2021 | 19229 | 0.210 |
Why?
|
| Cell Line, Transformed | 2 | 2018 | 898 | 0.210 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2021 | 17 | 0.210 |
Why?
|
| Armadillo Domain Proteins | 1 | 2021 | 22 | 0.210 |
Why?
|
| Leptin | 4 | 2017 | 1599 | 0.210 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 1017 | 0.210 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2015 | 209 | 0.200 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13102 | 0.200 |
Why?
|
| ras Proteins | 3 | 2016 | 1060 | 0.200 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 2187 | 0.200 |
Why?
|
| Blotting, Western | 5 | 2020 | 5179 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 11 | 2022 | 21827 | 0.190 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2022 | 212 | 0.190 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2020 | 38 | 0.190 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4204 | 0.190 |
Why?
|
| Liver | 3 | 2013 | 7474 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 944 | 0.180 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2016 | 237 | 0.180 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 433 | 0.180 |
Why?
|
| Blood Glucose | 2 | 2015 | 6256 | 0.180 |
Why?
|
| Tryptophan | 1 | 2022 | 478 | 0.180 |
Why?
|
| Mutation | 10 | 2023 | 29786 | 0.180 |
Why?
|
| Nucleic Acids | 1 | 2022 | 182 | 0.170 |
Why?
|
| Mutation, Missense | 4 | 2015 | 2564 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4931 | 0.170 |
Why?
|
| Cell Cycle Proteins | 3 | 2023 | 3462 | 0.170 |
Why?
|
| DNA, Complementary | 2 | 2018 | 2050 | 0.170 |
Why?
|
| Thiazoles | 2 | 2018 | 1483 | 0.170 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 317 | 0.170 |
Why?
|
| Phenylenediamines | 1 | 2019 | 90 | 0.170 |
Why?
|
| Reverse Transcription | 1 | 2018 | 47 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1655 | 0.170 |
Why?
|
| Lipids | 1 | 2010 | 3305 | 0.160 |
Why?
|
| Alleles | 4 | 2018 | 6933 | 0.160 |
Why?
|
| Estrogens | 2 | 2016 | 1566 | 0.160 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 399 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 873 | 0.160 |
Why?
|
| Gene Knockout Techniques | 3 | 2019 | 809 | 0.160 |
Why?
|
| Piperazines | 3 | 2018 | 2488 | 0.160 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1878 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 3523 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2023 | 1133 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2018 | 190 | 0.150 |
Why?
|
| Drug Design | 2 | 2018 | 1076 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2020 | 349 | 0.150 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 748 | 0.150 |
Why?
|
| DNA Damage | 2 | 2018 | 2432 | 0.140 |
Why?
|
| Cell Survival | 3 | 2016 | 5882 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1676 | 0.140 |
Why?
|
| Receptors, Leptin | 1 | 2017 | 360 | 0.140 |
Why?
|
| Neurons | 6 | 2017 | 9338 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 685 | 0.140 |
Why?
|
| Autophagy | 2 | 2016 | 1300 | 0.140 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 265 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 1364 | 0.140 |
Why?
|
| RNA, Double-Stranded | 1 | 2017 | 290 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 4554 | 0.130 |
Why?
|
| Protein Kinases | 3 | 2009 | 1640 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 203 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2023 | 901 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 390 | 0.130 |
Why?
|
| Cyclin C | 1 | 2014 | 14 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1526 | 0.130 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2015 | 164 | 0.130 |
Why?
|
| Peptide Library | 1 | 2016 | 349 | 0.130 |
Why?
|
| Glucose Intolerance | 2 | 2010 | 577 | 0.130 |
Why?
|
| Hypothalamus | 2 | 2011 | 1063 | 0.130 |
Why?
|
| Energy Metabolism | 5 | 2017 | 2899 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1276 | 0.120 |
Why?
|
| Insulin Resistance | 3 | 2015 | 3864 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.120 |
Why?
|
| Cancer Vaccines | 1 | 2022 | 1023 | 0.120 |
Why?
|
| Cell Line | 5 | 2015 | 15997 | 0.120 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2012 | 154 | 0.120 |
Why?
|
| Paclitaxel | 1 | 2021 | 1708 | 0.120 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 644 | 0.120 |
Why?
|
| Caspase 3 | 1 | 2016 | 758 | 0.120 |
Why?
|
| Homeostasis | 5 | 2015 | 3340 | 0.120 |
Why?
|
| Interferons | 1 | 2017 | 706 | 0.120 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2013 | 50 | 0.110 |
Why?
|
| Viruses | 1 | 2017 | 374 | 0.110 |
Why?
|
| Axons | 1 | 2021 | 1684 | 0.110 |
Why?
|
| Uterus | 1 | 2018 | 711 | 0.110 |
Why?
|
| Myoblasts | 1 | 2015 | 238 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 728 | 0.110 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 253 | 0.110 |
Why?
|
| Prodrugs | 1 | 2015 | 268 | 0.110 |
Why?
|
| Genes, erbB-2 | 1 | 2013 | 162 | 0.110 |
Why?
|
| Biological Assay | 1 | 2016 | 652 | 0.110 |
Why?
|
| Conserved Sequence | 1 | 2016 | 1202 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2012 | 261 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 789 | 0.110 |
Why?
|
| Glioma | 2 | 2018 | 3401 | 0.110 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2012 | 76 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2015 | 607 | 0.110 |
Why?
|
| Pyrimidinones | 1 | 2014 | 371 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.110 |
Why?
|
| Receptor, erbB-3 | 1 | 2013 | 142 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 987 | 0.100 |
Why?
|
| Eating | 2 | 2017 | 1536 | 0.100 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2012 | 114 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2016 | 695 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2016 | 2256 | 0.100 |
Why?
|
| Antigen Presentation | 1 | 2017 | 1284 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 502 | 0.100 |
Why?
|
| Lysine | 1 | 2016 | 1007 | 0.100 |
Why?
|
| Delayed-Action Preparations | 1 | 2015 | 968 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1821 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2017 | 3023 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 3 | 2014 | 1613 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 624 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1312 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2018 | 2499 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1580 | 0.100 |
Why?
|
| Genotype | 2 | 2017 | 12951 | 0.100 |
Why?
|
| Drug Delivery Systems | 3 | 2017 | 2219 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2016 | 942 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 1537 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 879 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3920 | 0.090 |
Why?
|
| Remission Induction | 1 | 2016 | 2386 | 0.090 |
Why?
|
| Indazoles | 1 | 2012 | 289 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 407 | 0.090 |
Why?
|
| DNA Repair | 2 | 2018 | 2046 | 0.090 |
Why?
|
| Epidermis | 1 | 2013 | 528 | 0.090 |
Why?
|
| Pyrimidines | 2 | 2019 | 2942 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 611 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2016 | 1285 | 0.090 |
Why?
|
| Nanostructures | 1 | 2015 | 551 | 0.090 |
Why?
|
| Erythropoiesis | 1 | 2014 | 705 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1376 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2013 | 1915 | 0.090 |
Why?
|
| Protein Binding | 4 | 2016 | 9386 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9239 | 0.080 |
Why?
|
| Bone Marrow | 2 | 2019 | 2948 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2017 | 1538 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 1790 | 0.080 |
Why?
|
| Transplantation, Heterologous | 2 | 2014 | 2382 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 783 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 13815 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.080 |
Why?
|
| Phosphotransferases | 1 | 2009 | 308 | 0.080 |
Why?
|
| Calcium | 1 | 2021 | 5756 | 0.080 |
Why?
|
| Rats | 4 | 2021 | 24260 | 0.080 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 851 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2541 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 2849 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6538 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2728 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1632 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2018 | 2725 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2011 | 578 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2019 | 234 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3505 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2020 | 15519 | 0.070 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2009 | 415 | 0.070 |
Why?
|
| Male | 18 | 2022 | 350118 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2016 | 3748 | 0.070 |
Why?
|
| Myristic Acid | 1 | 2005 | 47 | 0.070 |
Why?
|
| Chromatin | 1 | 2018 | 2934 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 252 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2015 | 1660 | 0.070 |
Why?
|
| Histones | 1 | 2016 | 2599 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 829 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 5686 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3616 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.070 |
Why?
|
| Proteins | 2 | 2018 | 6103 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2012 | 1938 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 708 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2023 | 63114 | 0.060 |
Why?
|
| Prostate | 2 | 2022 | 1774 | 0.060 |
Why?
|
| Brain | 3 | 2021 | 26385 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2017 | 2751 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5974 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4462 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2021 | 687 | 0.060 |
Why?
|
| Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1403 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 12261 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 2988 | 0.060 |
Why?
|
| Agar | 1 | 2003 | 56 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2005 | 2255 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 2635 | 0.060 |
Why?
|
| Anaphase | 1 | 2023 | 120 | 0.060 |
Why?
|
| Aspirin | 1 | 2015 | 3282 | 0.060 |
Why?
|
| Metformin | 1 | 2010 | 835 | 0.050 |
Why?
|
| Fertility | 2 | 2018 | 781 | 0.050 |
Why?
|
| Species Specificity | 1 | 2007 | 2478 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 1827 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2010 | 3002 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5853 | 0.050 |
Why?
|
| Acylation | 1 | 2022 | 107 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1791 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 443 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2016 | 1792 | 0.050 |
Why?
|
| Transfection | 2 | 2016 | 5892 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2012 | 11124 | 0.050 |
Why?
|
| Aging | 1 | 2021 | 8664 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2018 | 810 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1351 | 0.050 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 2216 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10943 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2018 | 713 | 0.050 |
Why?
|
| DNA | 1 | 2015 | 7301 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3752 | 0.050 |
Why?
|
| Stem Cells | 1 | 2014 | 3567 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2010 | 2043 | 0.050 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2020 | 58 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 1097 | 0.050 |
Why?
|
| Genes, cdc | 1 | 2020 | 116 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 8301 | 0.050 |
Why?
|
| Retroviridae | 1 | 2003 | 914 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12072 | 0.050 |
Why?
|
| Epilepsy | 1 | 2015 | 3310 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2003 | 1682 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3309 | 0.040 |
Why?
|
| Adipocytes | 1 | 2006 | 1184 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2020 | 188 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 871 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 546 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 4851 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2004 | 1058 | 0.040 |
Why?
|
| Estrus | 1 | 2017 | 81 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2021 | 622 | 0.040 |
Why?
|
| Decidua | 1 | 2018 | 86 | 0.040 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 582 | 0.040 |
Why?
|
| Obesity | 3 | 2016 | 12745 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2012 | 12208 | 0.040 |
Why?
|
| Androgens | 1 | 2004 | 1281 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2017 | 182 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 7913 | 0.040 |
Why?
|
| Glycine | 1 | 2020 | 671 | 0.040 |
Why?
|
| Solubility | 1 | 2018 | 1085 | 0.040 |
Why?
|
| Binding Sites | 1 | 2005 | 6114 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.040 |
Why?
|
| Fluphenazine | 1 | 2016 | 36 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 1182 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2016 | 31 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 794 | 0.040 |
Why?
|
| Serine | 1 | 2020 | 826 | 0.040 |
Why?
|
| RNA Interference | 3 | 2011 | 2889 | 0.030 |
Why?
|
| Chlorpromazine | 1 | 2016 | 111 | 0.030 |
Why?
|
| Gene Library | 2 | 2010 | 1074 | 0.030 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2018 | 358 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2018 | 272 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2017 | 265 | 0.030 |
Why?
|
| Imidazoles | 2 | 2012 | 1206 | 0.030 |
Why?
|
| Indans | 1 | 2016 | 96 | 0.030 |
Why?
|
| Growth | 1 | 2017 | 376 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 6386 | 0.030 |
Why?
|
| Cell Division | 1 | 2003 | 4568 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 875 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 547 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 2016 | 295 | 0.030 |
Why?
|
| Methylamines | 1 | 2016 | 123 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 3 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 1997 | 0.030 |
Why?
|
| Dopamine Antagonists | 1 | 2016 | 296 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2015 | 104 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 513 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 6314 | 0.030 |
Why?
|
| Neointima | 1 | 2015 | 135 | 0.030 |
Why?
|
| Puberty | 1 | 2017 | 490 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2016 | 440 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2019 | 1619 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 9648 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2017 | 517 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 846 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2015 | 500 | 0.030 |
Why?
|
| Benzimidazoles | 2 | 2012 | 850 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2017 | 584 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3420 | 0.030 |
Why?
|
| Proteomics | 2 | 2020 | 3638 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 1377 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 1106 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 205 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 92 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2015 | 371 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1783 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2016 | 618 | 0.030 |
Why?
|
| Castration | 1 | 2012 | 159 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 2203 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3129 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 798 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2016 | 781 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 2437 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2005 | 3444 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2016 | 1801 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2006 | 11483 | 0.030 |
Why?
|
| Time Factors | 3 | 2019 | 40075 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 1484 | 0.030 |
Why?
|
| Phenols | 1 | 2015 | 497 | 0.030 |
Why?
|
| KATP Channels | 1 | 2011 | 45 | 0.030 |
Why?
|
| Chromones | 1 | 2011 | 154 | 0.020 |
Why?
|
| Phenylthiohydantoin | 1 | 2012 | 193 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5751 | 0.020 |
Why?
|
| Genomics | 1 | 2007 | 5720 | 0.020 |
Why?
|
| TRPC Cation Channels | 1 | 2011 | 121 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 6773 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1086 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2011 | 390 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 241 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 2088 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 193 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3479 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2011 | 178 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2015 | 5456 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2010 | 203 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2010 | 110 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Androstadienes | 1 | 2011 | 346 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 1524 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 408 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2013 | 913 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 964 | 0.020 |
Why?
|
| Light | 1 | 2015 | 1374 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13284 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 697 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 399 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2011 | 1137 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2011 | 959 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 648 | 0.020 |
Why?
|
| Quinolines | 1 | 2012 | 732 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 956 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1547 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3772 | 0.020 |
Why?
|
| Benzamides | 1 | 2012 | 1379 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 2007 | 295 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 2557 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 2171 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1356 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 893 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 365 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3703 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2016 | 2585 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1905 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 2025 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2015 | 1972 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 4420 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 4669 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 6473 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2007 | 530 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 704 | 0.010 |
Why?
|
| Calmodulin | 1 | 2003 | 209 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16365 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4364 | 0.010 |
Why?
|
| Karyopherins | 1 | 2003 | 137 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3188 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.010 |
Why?
|
| Cell Movement | 1 | 2015 | 5217 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 2003 | 248 | 0.010 |
Why?
|
| Indoles | 1 | 2010 | 1839 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2010 | 2017 | 0.010 |
Why?
|
| Testosterone | 1 | 2012 | 2420 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 431 | 0.010 |
Why?
|
| Pyridines | 1 | 2013 | 2825 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 1102 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 214055 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
| Child | 2 | 2018 | 77709 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 730 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 2839 | 0.010 |
Why?
|
| Genome | 1 | 2007 | 1808 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 2007 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 13881 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29144 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2969 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 213383 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23338 | 0.010 |
Why?
|
| Melanoma | 1 | 2010 | 5510 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18111 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 163280 | 0.000 |
Why?
|